Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial.
Megumi Oshima , Brendon L Neuen, Meg J Jardine, George Bakris, Robert Edwards, Adeera Levin, Kenneth W Mahaffey, Bruce Neal, Carol Pollock, Norman Rosenthal, Takashi Wada, David C Wheeler, Vlado Perkovic, Hiddo J L Heerspink.
Lancet Diabetes Endocrinol 8(11):903-914, 2020